Pediatric Migraine

Recruiting

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

Pediatric Migraine
Enter your postal code
to see sites near you
Recruiting

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

Pediatric Migraine
Enter your postal code
to see sites near you
Not the right fit? Sign up to receive updates on new trials.